Opioid Use Disorder (oud) Clinical Trials
2 recruiting trials for Opioid Use Disorder (oud). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Opioid Use Disorder (oud) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Hospices Civils de Lyon (1), University of California, San Francisco (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is DIADEME strategy (procedure, 1 trial), followed by Controle strategy, Individual semi directive interview.
Track Opioid Use Disorder (oud) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Autonomous Methadone Delivery System by Nurses
Initiations of methadone treatment for opiode use disorder (OUD) are carried out in France in specialized centers, known as centers for care, support and prevention in addictology...
Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder
The purpose of this study is to determine if personalized (adaptive) Deep Brain Stimulation (DBS) based upon invasive brain mapping is safe and can lead to better outcomes like...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Opioid Use Disorder (oud), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Opioid Use Disorder (oud), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Opioid Use Disorder (oud), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.